SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elmer who wrote (1323)7/8/2002 2:20:53 AM
From: Doc Bones  Read Replies (1) of 3158
 
I think the excessive caution and bureaucratic inertia of the pharmas has been costly to biotech. Logically they should have been a lot more aggressive about filling their pipelines with munches and other deals.

In the first quarter, when the pharmas were holding up while biotech dumped, I could almost hear the pharmas tip-toeing along:

"Don't pay any attention to us, we're solid-as-a-rock NYSE companies. We have nothing to do with those crazy Nasdaq biotechs - never had any faith in them."

Now that pharmas have been taking some (overdue) whacks themselves, maybe they can loosen up and admit that biotechs have a lot to offer them, especially at these prices.

And maybe some of the larger egos running biotechs now realize they're not Masters of the Universe, and that they could use some help.

Doc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News